Search

Your search keyword '"Bente Juel Riis"' showing total 90 results

Search Constraints

Start Over You searched for: Author "Bente Juel Riis" Remove constraint Author: "Bente Juel Riis" Topic medicine.disease Remove constraint Topic: medicine.disease
90 results on '"Bente Juel Riis"'

Search Results

1. The Efficacy and Safety of Multiple Dose Regimens of Kudzu (Pueraria lobata) Root Extract on Bone and Cartilage Turnover and Menopausal Symptoms

2. Atrial fibrillation is associated with lean body mass in postmenopausal women

3. Eighteen Months of Treatment With Subcutaneous Abaloparatide Followed by 6 Months of Treatment With Alendronate in Postmenopausal Women With Osteoporosis

4. THU0419 BIOMARKERS OF BONE AND CARTILAGE TURNOVER CTX-I AND CTX-II PREDICT TOTAL JOINT REPLACEMENTS IN OA

5. Associations between biomarkers of bone and cartilage turnover, gender, pain categories and radiographic severity in knee osteoarthritis

6. Bone mineral density response rates are greater in patients treated with abaloparatide compared with those treated with placebo or teriparatide: Results from the ACTIVE phase 3 trial

7. FRI0530 Total joint replacement (TJR) as clinical endpoint in oa; prevalence and incidence rates of tjrs from the prospective epidemiologic risk factor (PERF I) study

8. Identification of pain categories associated with change in pain in patients receiving placebo: data from two phase 3 randomized clinical trials in symptomatic knee osteoarthritis

9. OP0165 A neoepitope fragment of c-reactive protein is prognostic of radiographic knee oa

10. Serum endotrophin identifies optimal responders to PPARγ agonists in type 2 diabetes

11. SQ HDM SLIT-tablet (ALK) in treatment of asthma – Post hoc results from a randomised trial

12. Efficacy of a House Dust Mite Sublingual Allergen Immunotherapy Tablet in Adults With Allergic Asthma: A Randomized Clinical Trial

13. Efficacy of monthly oral ibandronate is sustained over 5 years: the MOBILE long-term extension study

14. Urinary excretion of pyridinoline crosslinks correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosis

15. Bone Metabolism and Bone Status in Osteoporotic Patients

16. Adverse effects of a SERM (Levormeloxifene)

17. Norethisterone acetate in combination with estrogen: Effects on the skeleton and other organs

18. Efficacy of Levormeloxifene in the Prevention of Postmenopausal Bone Loss and on the Lipid Profile Compared to Low Dose Hormone Replacement Therapy1

19. Monofluorophosphate Combined with Hormone Replacement Therapy Induces a Synergistic Effect on Bone Mass by Dissociating Bone Formation and Resorption in Postmenopausal Women: A Randomized Study1

20. Forearm bone mass and biochemical markers of bone remodelling in normal Chinese women

21. Low bone mass and fast rate of bone loss at menopause: Equal risk factors for future fracture: A 15-year follow-up Study

22. Effect of Abaloparatide vs Placebo on New Vertebral Fractures in Postmenopausal Women With Osteoporosis

23. OP0092 Identification of Pain Subtypes Associated with Placebo-Response: Data from Two Phase 3 Randomized Clinical Trials in Symptomatic Knee Osteoarthritis

24. Applications of an enzyme immunoassay for a new marker of bone resorption (CrossLaps): follow-up on hormone replacement therapy and osteoporosis risk assessment

25. Evaluation of the efficacy, safety and pharmacokinetic profile of oral recombinant human parathyroid hormone [rhPTH(1-31)NH(2)] in postmenopausal women with osteoporosis

26. The diagnostic validity of urinary free pyridinolines to identify women at risk of osteoporosis

28. Comparison of vitamin D metabolism in early healthy and late osteoporotic postmenopausal women

29. Serum Bone Gla Protein: A Potential Marker of Growth Hormone (GH) Deficiency and the Response to GH Therapy

30. AB0839 Identification of a Inflammatory Phenotype with Higher Likelihood of Progression in OA: Analysis of Womac Pain Sub-Questions, C3M and U-CTX-II from Two Phase 3 Randomized Clinical Trials with Treatment of Symptomatic Knee Osteoarthritis

31. THU0454 OA Pain Phenotypes Associated with Structural Progression and Change in Pain Over Time in Two Phase III Clinical Studies with Symptomatic Knee OA

32. THU0453 Biomarkers of Bone and Cartilage Remodeling in OA is Strongly Associated with Pain and Obesity: Data from Two Phase 3 Randomized Clinical Trials in Symptomatic Knee OA

33. OP0248 Responder Analysis of the Effects of Abaloparatide (Parathyroid Hormone Related Peptide) and Teriparatide on Bone Mineral Density in Postmenopausal Women with Osteoporosis: Results of the Active Trial

34. Different Effects of CSA and CSB Deficiency on Sensitivity to Oxidative DNA Damage

35. Nasal salmon calcitonin in osteoporosis

36. Biochemical markers of bone turnover to monitor the bone response to postmenopausal hormone replacement therapy

37. Bleeding pattern and climacteric symptoms during different sequential combined HRT regimens in current use

38. Human growth hormone and growth hormone releasing hormone: a double-masked, placebo-controlled study of their effects on bone metabolism in elderly women

39. Biochemical markers of bone turnover. II: Diagnosis, prophylaxis, and treatment of osteoporosis

40. Serum placental protein 14 (PP14) reflects endometrial status during hormone replacement therapy

41. Discriminatory ability of bone mass measurements (SPA and DEXA) for fractures in elderly postmenopausal women

42. Desogestrel in hormone replacement therapy: long-term effects on bone, calcium and lipid metabolism, climacteric symptoms, and bleeding

43. Role of peak bone mass and bone loss in postmenopausal osteoporosis: 12 year study

44. The carboxy-terminal propeptide of type I procollagen in serum as a marker of bone formation: the effect of nandrolone decanoate and female sex hormones

45. Potential risk factors for development of postmenopausal osteoporosis--examined over a 12-year period

46. Screening procedure for women at risk of developing postmenopausal osteoporosis

47. 17 Beta-estradiol and continuous norethisterone: a unique treatment for established osteoporosis in elderly women

48. Bone mass measured by photon absorptiometry: comparison of forearm, heel, and spine

49. Hormonal replacement therapy and the skeletal system

50. Discontinuous calcitonin treatment of established osteoporosis--effects of withdrawal of treatment

Catalog

Books, media, physical & digital resources